PAC-FragmentDEL - photoactivated covalent capture of DNA-encoded fragments for hit discovery.
Journal
RSC medicinal chemistry
ISSN: 2632-8682
Titre abrégé: RSC Med Chem
Pays: England
ID NLM: 101759460
Informations de publication
Date de publication:
16 Nov 2022
16 Nov 2022
Historique:
received:
28
06
2022
accepted:
03
08
2022
entrez:
25
11
2022
pubmed:
26
11
2022
medline:
26
11
2022
Statut:
epublish
Résumé
We describe a novel approach for screening fragments against a protein that combines the sensitivity of DNA-encoded library technology with the ability of fragments to explore what will bind. Each of the members of the library consists of a fragment which is linked to a photoactivatable diazirine moiety. Split and pool synthesis combines each fragment with a set of linkers with the version of the library reported here containing some 70k different compounds, each with an individual DNA code. Incubation of the library with a protein sample is followed by photoactivation, washing and subsequent PCR and sequencing which allows the individual fragment hits to be identified. We illustrate how the approach allows successful hit fragment identification using only microgram quantities of material for two targets. PAK4 is a kinase for which conventional fragment screening has generated many advance leads. The as yet undrugged target, 2-epimerase, presents a more challenging active site for identification of hit compounds. In both cases, PAC-FragmentDEL identified fragments validated as hits by ligand-observed NMR measurements and crystal structure determination of off-DNA sample binding to the proteins.
Identifiants
pubmed: 36426238
doi: 10.1039/d2md00197g
pii: d2md00197g
pmc: PMC9667776
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1341-1349Informations de copyright
This journal is © The Royal Society of Chemistry.
Déclaration de conflit d'intérêts
There are no conflicts to declare. All authors are employees of either Vernalis (R&D) Ltd or HitGen who funded the research.
Références
J Chem Inf Model. 2009 Feb;49(2):377-89
pubmed: 19434839
Acc Chem Res. 2015 Mar 17;48(3):722-30
pubmed: 25687211
Acta Crystallogr D Biol Crystallogr. 1997 May 1;53(Pt 3):240-55
pubmed: 15299926
Proc Natl Acad Sci U S A. 1992 Jun 15;89(12):5381-3
pubmed: 1608946
Chem Commun (Camb). 2019 Mar 26;55(26):3753-3756
pubmed: 30860533
Nat Chem. 2015 Mar;7(3):241-9
pubmed: 25698334
J Comput Aided Mol Des. 2009 Aug;23(8):603-20
pubmed: 19495994
J Med Chem. 2022 Jan 13;65(1):84-99
pubmed: 34928151
PLoS One. 2013 Apr 10;8(4):e60754
pubmed: 23593301
Curr Opin Chem Biol. 2011 Aug;15(4):489-96
pubmed: 21665521
Drug Discov Today. 2004 May 15;9(10):430-1
pubmed: 15109945
Drug Discov Today. 2005 Dec;10(23-24):1675-82
pubmed: 16376828
Nat Rev Drug Discov. 2016 Sep;15(9):605-619
pubmed: 27417849
ACS Pharmacol Transl Sci. 2021 Jun 14;4(4):1265-1279
pubmed: 34423264
Acta Crystallogr D Biol Crystallogr. 2011 Apr;67(Pt 4):235-42
pubmed: 21460441
Curr Opin Pharmacol. 2009 Oct;9(5):615-21
pubmed: 19477685
J Biomol NMR. 2001 Dec;21(4):349-59
pubmed: 11824754
Nat Biotechnol. 2004 May;22(5):568-74
pubmed: 15097996
Nat Rev Drug Discov. 2016 Oct;15(10):679-98
pubmed: 27516170
Acta Crystallogr D Biol Crystallogr. 2004 Dec;60(Pt 12 Pt 1):2126-32
pubmed: 15572765
Acta Crystallogr D Struct Biol. 2017 Feb 1;73(Pt 2):112-122
pubmed: 28177307
Medchemcomm. 2016 Oct 1;7(10):2020-2027
pubmed: 28948007
Drug Discov Today. 2011 Apr;16(7-8):284-7
pubmed: 21315179
Angew Chem Int Ed Engl. 2020 Nov 16;59(47):21096-21105
pubmed: 32745361
Acta Crystallogr D Biol Crystallogr. 2010 Feb;66(Pt 2):125-32
pubmed: 20124692
Cell. 2017 Jan 26;168(3):527-541.e29
pubmed: 28111073
Angew Chem Int Ed Engl. 1999 Jun 14;38(12):1784-1788
pubmed: 29711196
EMBO Rep. 2008 Feb;9(2):199-205
pubmed: 18188181
J Med Chem. 2016 Sep 22;59(18):8189-206
pubmed: 27124799
J Med Chem. 2018 Aug 23;61(16):6945-6963
pubmed: 29683660
ACS Med Chem Lett. 2013 Dec 12;4(12):1142-1147
pubmed: 24443700
Nat Chem Biol. 2009 Sep;5(9):647-54
pubmed: 19648931
Bioorg Med Chem. 2021 Jul 15;42:116223
pubmed: 34091303